HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introduction.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Ong, K Jvan Hoek, A J
Harris, R J
Figueroa, J
Waters, L
Chau, C
Croxford, S
Kirwan, P
Brown, A
Postma, M J
Gill, O N
Delpech, V
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introduction.Published in
HIV Med 2019; 20(6):377-91PMID
31034159ae974a485f413a2113503eed53cd6c53
10.1111/hiv.12725
Scopus Count
Collections
Related articles
- Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
- Authors: Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA
- Issue date: 2007 Nov 13
- Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.
- Authors: Dhamija P, Bansal D, Medhi B
- Issue date: 2009 Jul
- Do generics offer significant savings to the UK National Health Service?
- Authors: Kanavos P
- Issue date: 2007 Jan
- Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014-2018.
- Authors: Hill A, Hill T, Jose S, Pozniak A
- Issue date: 2014
- Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.
- Authors: Simpson KN, Luo MP, Chumney EC, King MS, Brun S
- Issue date: 2007